Meeting
2015 Gastrointestinal Cancers Symposium
Strategy for cStage4 colorectal cancer: Chemotherapy or resection of primary tumor?
Authors
Shigeyoshi Iwamoto
Department of Surgery, Kansai Medical University Hirakata Hospital, Hirakata, Japan
Shigeyoshi Iwamoto , Madoka Hamada , Masaharu Oishi , Tatsuma Sakaguchi , Taku Michiura , Kentaro Inoue , A-Hon Kwon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 779)
DOI
10.1200/jco.2015.33.3_suppl.779
Abstract #
779
Poster Bd #
F17
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
PROX: Primary resistance to oxaliplatin containing regimen in the first line treatment of metastatic colorectal carcinoma—Retrospective analysis.
First Author: Larissa Machado
Poster
2016 Gastrointestinal Cancers Symposium
The ATOM trial: A multicenter, randomized phase II study of modified FOLFOX6 plus bevacizumab and modified FOLFOX6 plus cetuximab for colorectal cancer with liver-limited metastases.
First Author: Yasunori Emi
Poster
2015 Gastrointestinal Cancers Symposium
Randomized phase II studies comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining bevacizumab or cetuximab with FOLFOX or FOLFIRI.
First Author: Marc Van Den Eynde
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Preoperative chemotherapy prior to primary tumor resection for asymptomatic synchronous unresectable colorectal liver-limited metastases: A multicenter randomized controlled trial.
First Author: Qi Lin